Amy E. Krambeck, MD, discusses her recent trial1comparing the efficacy of Trilogy and ShockPulse-SE lithotripters used in percutaneous nephrolithotomy (PCNL). Krambeck et al found that both devices are highly efficient and serve as notable advancements in stone-removal technologies, although fewer device malfunctions were reported when the Trilogy device was utilized.
In 2017, the ShockPulse-SE was introduced by Olympus America as a unique lithotripter that produces 300 Hz of ballistic force. In 2018, the ultrasonic-ballistic, single-probe lithotripter Trilogy was invented by EMS and Boston Scientific. Trilogy has not been measured against its competitors, thus this study tested Trilogy’s efficacy against ShockPulse-SE.
In this interview, Krambeck, a professor of Urology, Department of Urology, Northwestern University, Feinberg School of Medicine, discusses the background and results of the study, as well as how the findings will affect her clinical practice.
“For harder, more aggressive stones, I'm more likely to use the Trilogy based on the results of the study. If I have a softer, easier stone, I prefer the lightness of the ShockPulse—so I'm probably going to use the ShockPulse for something that doesn't require all the power that's necessary behind the Trilogy,” Krambeck says in the video.
Reference
1. Large T, Nottingham C, Brinkman E, et al. Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy trial [published online ahead of print August 16, 2021]. Journal of Endourology. doi:10.1089/end.2020.1097
Bundled payment program covers kidney stone care
July 22nd 2024"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.
FDA grants 510(k) clearance to Ambu’s single-use ureteroscope
July 2nd 2024"This clearance in the US of our new ureteroscopy solution not only demonstrates a market expansion for Ambu; it is a testament to the progressive shift towards single-use solutions within the field of urology," says Britt Meelby Jensen.
Data support shock wave lithotripsy for pediatric patients with kidney stones
May 28th 2024Regarding patient-reported outcomes, those who underwent URS showed higher urinary symptoms, greater pain intensity, and greater pain interference at 1 week following surgery compared with those who underwent SWL.